Live Breaking News & Updates on Rajan ravichandran

Stay informed with the latest breaking news from Rajan ravichandran on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Rajan ravichandran and stay connected to the pulse of your community

IIT Madras-designed trial shows efficacy of Indomethacin drug in treating mild, moderate COVID-19 patients

The trials designed by the researchers at the Indian Institute of Technology (IIT) Madras have shown the excellent efficacy of Indomethacin, a non-steroidal anti-inflammatory drug as an antiviral agent in the treatment of mild and moderate COVID-19 patients.

Italy , Madras , Tamil-nadu , India , Italian , R-krishna-kumar , Kris-gopalakrishnan , Rajan-ravichandran , Panimalar-medical-college , Research-institute , Indian-institute-of-technology , Indian-institute

IIT Madras trial on anti-inflammatory drug shows promise for COVID-19 patients

Indomethacin has more than 2 million prescriptions per year in the US alone

Hyderabad , Andhra-pradesh , India , Chennai , Tamil-nadu , Madras , Rajan-ravichandran , Journal-of-the-indian-medical-association , Indian-institutes-of-technology , Image-credit , Indian-institutes , Director-nephrology

IIT Madras-designed trial shows efficacy of Indomethacin drug in treating mild, moderate COVID-19 patients

IIT Madras-designed trial shows efficacy of Indomethacin drug in treating mild, moderate COVID-19 patients
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

Italy , Madras , Tamil-nadu , India , Italian , R-krishna-kumar , Kris-gopalakrishnan , Rajan-ravichandran , Panimalar-medical-college , Research-institute , Indian-institute-of-technology , Indian-institute

Indomethacin highly effective in treating COVID-19 infection: Study

The study was conducted by Dr Rajan Ravichandran, Director Nephrology, MIOT Hospitals and Prof R Krishna Kumar, Institute Professor, IIT Madras in India

Wardha , Maharashtra , India , Chennai , Tamil-nadu , Madras , Nellore , Andhra-pradesh , R-krishna-kumar , Rajan-ravichandran , Datta-meghe-institute-of-medical-sciences , Panimalar-medical-college

Indomethacin highly effective in treating covid infection: Study

The study was conducted by Dr Rajan Ravichandran, Director Nephrology, MIOT Hospitals and Prof R Krishna Kumar, Institute Professor, IIT Madras in India

Wardha , Maharashtra , India , Chennai , Tamil-nadu , Madras , Nellore , Andhra-pradesh , R-krishna-kumar , Rajan-ravichandran , Datta-meghe-institute-of-medical-sciences , Panimalar-medical-college

Researchers to study Indomethacin's impact on oxygen need in Covid patients

Researchers to study Indomethacin’s impact on oxygen need in Covid patients
April 28, 2021
×
After seeing encouraging results in a pilot study done last year, Indian researchers are now planning to conduct a randomised control trial (RCT) to understand the efficacy and safety of indomethacin in providing faster symptomatic relief and reduction in oxygen requirement in Covid-19 patients.
Indomethacin is a nonsteroidal, anti-inflammatory drug (NSAID) commonly used to reduce fever, pain, stiffness, and swelling caused by rheumatoid arthritis.
In December 2020, Medrxiv published a preprint of a study conducted by a group of doctors, who advanced the case use of Indomethacin for faster symptomatic relief and preventing progression of pneumonia in Covid-19 patients.

Wardha , Maharashtra , India , Chennai , Tamil-nadu , Nellore , Andhra-pradesh , R-krishna-kumar , Rajan-ravichandran , Datta-meghe-institute-of-medical-sciences , Department-of-engineering-design , Indian-council-for-medical-research

Kidney transplant survivors and donors share success stories

Kidney transplant survivors and donors share success stories
“For me, age is just a number,” said Mohammed Lahiri (63), a kidney transplant survivor, stressing that the transplant was not a deterrent in any way to leading a normal life.
Share Via Email
| A+A A-
Sapiens Health Foundation founder Rajan Ravichandran interacting with kidney transplant survivors and donors, in Chennai on Friday. (Photo | P Jawahar/EPS)
By Express News Service
CHENNAI: ‘End-stage kidney disease is not end of life.’ That was the message conveyed at the World Kidney Day celebrations by the Sapiens Health Foundation on Thursday. The event saw scores of kidney transplant survivors and donors sharing experiences.

Chennai , Tamil-nadu , India , Mohammed-lahiri , Mt-everest , Rajan-ravichandran , Maadhu-balaji , Sapiens-health-foundation-on , Sapiens-health-foundation , News-service , Express-news , World-kidney-day

Documentary film about kidney ailments released

Documentary film about kidney ailments released
Updated:
Updated:
World Kidney Day event organised by Sapiens Foundation
Share Article
AAA
Hale and hearty: World Kidney Day 2021 celebrations being held at Sapiens Health Foundation in Chennai on Thursday.

World Kidney Day event organised by Sapiens Foundation
Sixty-three-year-old Mohammed Lahiri goes paragliding every year.
“I have also gone for trekking and mountain climbing. I want to celebrate life in every possible way after nearly embracing death,” he said.
Mr. Lahiri went through a kidney transplant nearly 33 years ago and said he continued to do everything with ease.
Speaking on the occasion of World Kidney Day, organised by Sapiens Health Foundation, he said, “Now my next aim is to run half a marathon and climb to the base camp of Mount Everest. I want to live till the age of 100 to show the world that this could be the lifespan of a person who has undergone transplant.”

Madhu-balaji , Mount-everest , Rajan-ravichandran , Mohammed-lahiri , Sapiens-health-foundation , Sixty-three-year-old-mohammed-lahiri , World-kidney-day , Documentary , Kidney-ailments , Released , மது-பாலாஜி , ஏற்ற-எவரெஸ்ட்

India Coronavirus Dispatch: How the lockdown upended Adivasi communities

India’s unplanned lockdown unleashed fresh hell for its Adivasis
The lockdown imposed in March took the general public by surprise and several sections of society were reeling from it for months. The Adivasis and other forest-dwelling communities, which at 104 million individuals make up 8.6% of the population, were particularly hard hit.
Since the Adivasi communities live in remote areas, information about the disease was not adequately available, to begin with. These communities who have been marginalised in terms of access to healthcare were badly hit as Covid-19 impacts people with compromised health conditions and low immunity. A complete lockdown, restricted entry to forests and closed markets are all factors that have increased their vulnerability as they depend on the forests for their livelihoods and several other purposes. The absence of government support worsens their position, the writer of the article says.

India , Chennai , Tamil-nadu , Madras , Rajan-ravichandran , Department-of-engineering-design , Linkedin , Indian-institute-of-technology , Young , Engineering-design , Indian-institute , Quarterly-reviews

Coronavirus live updates | Pandemic far from over, warns WHO official

Oxford/AstraZeneca vaccine set to clearance by year-end: Report
The Oxford University vaccine against coronavirus (COVID-19) being produced by AstraZeneca is likely to get regulatory approval from the U.K.’s independent regulator by the end of this year for a roll-out to begin in early 2021, according to a U.K. media report.
The Medicines and Healthcare Regulatory Agency (MHRA), which had been formally tasked by the U.K. government last month with the process of clearance after the jab emerged safe and effective against the novel coronavirus in human trials, is expected to authorise the vaccine by December 28 or 29 after the final data is provided on Monday,

Wardha , Maharashtra , India , Australia , Sydney , New-south-wales , Nellore , Andhra-pradesh , Italy , Veneto , Kerala , Madras